A Phase II Open Randomized Comparison of 566C80 and Pentamidine Isethionate for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients Who Are Intolerant of Trimethoprim / Sulfamethoxazole

NCT00001996 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Pneumonia, Pneumocystis Carinii
HIV Infections

Interventions

DRUG: Atovaquone
DRUG: Pentamidine isethionate

Sponsor

Glaxo Wellcome